Abubacar, Zayd .

HRN: 22-25-25  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2022
CEFUROXIME 1.5GM (VIAL)
11/25/2022
12/01/2022
IVT
325mg
Q8
URTI
Waiting Final Action 
11/27/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/27/2022
12/03/2022
PO
3.9 Ml
Q12
T/C UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: